Haven't had much time lately? Here's what you may have missed in the last few months
The 2015 updates of the Management of Oral and Gastrointestinal Mucosal Injury, Prostate Cancer and Malignant Pleural Mesothelioma guidelines are now available.
31 Jul 2015
HPV16 DNA is detected infrequently post-treatment in patients with oropharyngeal carcinoma, but may be predictive of disease recurrence
30 Jul 2015
Skin reactions associated with the anti-programmed death-1 agent pembrolizumab may predict progression-free survival
29 Jul 2015
Haematological malignancy patients could benefit from greater access to palliative care services
28 Jul 2015
Palliative chemotherapy use is of “questionable benefit” for end-stage cancer patients
27 Jul 2015
M.J. Van den Bent provides expert insights on results from studies in CNS malignancies presented at ASCO 2015 Annual Meeting.
M.J. Van den Bent provides expert insights on results from studies in CNS malignancies presented at ASCO 2015 Annual Meeting. In particular, he elaborates findings from the study presented at Plenary session on cognitive effects of the whole brain radiation therapy added to radiosurgery in patients with 1 to 3 brain metastases; then discuss on TTF added to standard chemo- and radiotherapy in newly diagnosed glioblastoma and results of radiochemotherapy studies in anaplastic glioma and astrocytoma.